CCL2 and breast carcinoma: However, inhibition of TBK1 in breast cancer cells (e.g., MDA-MB-231-Br, BT-474-Br, and 4T1 cells) did not affect the expression of GM-CSF and CCL2 (SI Appendix, Fig. S5A).